Publications by authors named "Changshan Song"

Claim this Profile
R
Rational design of NAMPT-based dual inhibitors with improved drug-like and pharmacokinetic properties for cancer treatment.
Jinke Lv, Binbin Cheng, Changshan Song

Eur J Med Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020-2024).
Binbin Cheng, Jinke Lv, Yao Xiao, Changshan Song, Jianjun Chen

Eur J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRDX1 stimulates non-small-cell lung carcinoma to proliferate via the Wnt/β-Catenin signaling.
Changshan Song, Gang Xiong, Shengli Yang, Xiaoqun Wei, Xiaowei Ye

Panminerva Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and Antivascular Targeted Therapy in Patients' Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge.
Bairu Shen, Zi Guo, Peng Huang, Minghua Tan, Xiaoshen Zhang, Changshan Song

J Immunol Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diosmetin Affects Gene Expression on Human Lung Adenocarcinoma Cells.
Changshan Song, Shunfu Deng, Hui Hu, Zheng Zheng, Bairu Shen

J Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status of Malignant Tumors after Organ Transplantation.
Bairu Shen, Zhuofei Cen, Minghua Tan, Changshan Song, Xuhui Wu

Biomed Res Int· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Meta-Analysis of Bevacizumab Combined with Platinum-Based Treatment of Malignant Pleural Effusions by Thoracic Perfusion.
Bairu Shen, Minghua Tan, Zhengyu Wang, Changshan Song, Hui Hu

J Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis.
Changshan Song, Pingfang Lu, Guoqiang Sun, Lin Yang, Zhigang Wang

Biochem Biophys Res Commun· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
Changshan Song, Pingfang Lu, Weicheng Shi, Guoqiang Sun, Guangsuo Wang

Biomed Pharmacother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis